According to the findings of a study presented today at the 48th Annual Conference on Cardiovascular Disease Epidemiology and Prevention, hosted by the American Heart Association, many teenagers invest as much time watching television and …

A study that will be published in the upcoming issue of Thorax suggests that a small dose of aspirin on alternate days may reduce the risk of developing asthma among women. The study included 40,000 …

A consumer watchdog group, the Organic Consumers Association (OCA), has recently uncovered small amounts of a petroleum-based ingredient, known to cause cancer in animals, in some cleaning and personal grooming products manufactured and distributed by …

On Friday, the US Food and Drug Administration (FDA) announced that it is taking action against shipments of heparin coming into the country from China after an influx of reports describing allergic reactions, including four …

Women who smoke during pregnancy are more likely to give birth to babies with behavioral problems, according to a study reported in the current issue of the Journal of Epidemiology and Community Health. The …

Researchers associated with the Mayo Clinic in Scottsdale, Arizona, have disclosed promising results from a new method of treating heart attack patients when their cardiac arrest occurs outside a hospital setting. In 2004, the …

Patient demographics has led researchers at the Johns Hopkins Kimmel Cancer Center to identify two types of cancer associated with the head and neck and the types of people more likely to get one form …

Outrage is spreading across the United States Senate floor faster than a summer wildfire. The Associated Press released a study indicating that tainted water is steadily flowing through American pipe line systems. The report stated …

Three Japanese companies recently recalled the drug, heparin, because its manufacturer in Wisconsin uses ingredients from China. They cite precaution as their reason for the recall. Scientific Protein Laboratories in Waunakee, Wisconsin, gets …

Researchers at Massachusetts General Hospital report good news for the drug, Femara (letrozole), used to prevent the recurrence of some forms of breast cancer, even when started long after the initial course of treatment has …